Cited by 3Prion Diseases and Protein MisfoldingAlzheimer's disease research and treatmentsAmyloidosis: Diagnosis, Treatment, Outcomes

Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity

Open access
Reimann, Regina R., Puzio, Martina, Rosati, Antonella, Emmenegger, Marc, Schneider, Bernard L., Valdés, Pamela, Huang, Danzhi, Caflisch, Amedeo +1 more·2023·Brain Pathology

Published version of a preprint

Abstract

The cellular prion protein PrP C mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP C (GDL) can also initiate neurotoxicity by inducing an intramolecular R 208 ‐H 140 hydrogen bond (“H‐latch”) between the α2‐α3 and β2‐α2 loops of PrP C . Importantly, GDL that suppresses the H‐latch prolong the life of prion‐infected mice, suggesting that GDL toxicity and prion infections exploit convergent pathways. To define the structural underpinnings of these phenomena, we transduced 19 individual PrP C variants to PrP C ‐deficient cerebellar organotypic cultured slices using adenovirus‐associated viral vectors (AAV). We report that GDL toxicity requires a single N‐proximal cationic residue (K 27 or R 27 ) within PrP C . Alanine substitution of K 27 also prevented the toxicity of PrP C mutants that induce Shmerling syndrome, a neurodegenerative disease that is suppressed by co‐expression of wild‐type PrP C . K 27 may represent an actionable target for compounds aimed at preventing prion‐related neurodegeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bpa.13130

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Reimann, R. R., Puzio, M., Rosati, A., Emmenegger, M., Schneider, B. L., Valdés, P., Huang, D., Caflisch, A., & Aguzzi, A.
Affiliations
  • University of Zurich (CH)
  • École Polytechnique Fédérale de Lausanne (CH)
  • Department of Biochemistry University of Zürich Zürich Switzerland
Corresponding author
  • Reimann, Regina R.
  • Aguzzi, Adriano
Venue
Brain Pathology
Publisher
Wiley
Published
2022-11-03
Volume
33
Issue
2
Pages
e13130-e13130
ISSN
  • 1015-6305 (ISSN-L)
  • 1750-3639
OpenAlex
W4308182087
Cited by
3
References
3
Citations by year
2025: 2 · 2023: 1
FWCI
0.24
Type
journal article
Language
en
Open access
Locations
  • Brain Pathology (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Human Frontier Science Program (ID RGP0001/2022)
  • Michael J. Fox Foundation (ID MJFF‐022156)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (ID 179040, ID 207872, ID 183563)
  • Stavros Niarchos Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
Keywords
cellular prion protein, intramolecular hydrogen bonding, neurotoxicity, cationic residues, prion infection, neurodegeneration
MeSH terms
Prion Proteins, Animals, Antibodies, Prions, Prion Diseases, Neurodegenerative Diseases, Mice, Reverse Genetics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review